Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Zentralblatt Fur Gynakologie|January 1, 1982
[Impact of synthetic sexual steroids on blood volume (author's transl)]G Klinger, W Stoll, G Zinner, et al.Biomedizinische Technik. Biomedical Engineering|December 6, 2002
[Comparative analysis of in vitro test procedures for evaluating hemocompatibility of cardiovascular stents]A Gebert, D Behrend, G Zinner, et al.Journal of Biomaterials Applications|November 18, 2000
Assessment of explanted PTCA balloonsD Behrend, G Zinner, K Sternberg, et al.Clinical Lung Cancer|March 5, 2010
Comparison of patient outcomes according to histology among pemetrexed-treated patients with stage IIIB/IV non-small-cell lung cancer in two phase II trialsRalph G Zinner, Silvia Novello, Guangbin Peng, et al.Zeitschrift Fur Erkrankungen Der Atmungsorgane|January 1, 1985
[Follow-up studies and special cardiologic diagnosis in patients with suspected heart sarcoidosis]D Kirsten, H Schaedel, H Schmidt, et al.Clinical Lung Cancer|September 15, 2010
Treatment rationale and study design for a randomized trial of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small-cell lung cancer of nonsquamous histologyRalph G Zinner, Scott B Saxman, Guangbin Peng, et al.Zeitschrift Fur Erkrankungen Der Atmungsorgane|January 1, 1985
[Thallium myocardial scintigraphy, hemodynamics and left ventricular wall kinetics in patients with suspected myocardial sarcoidosis]H Schaedel, D Kirsten, D Gottschild, et al.Clinical Lung Cancer|October 30, 2018
Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of CareJyoti D Patel, Luis Paz-Ares, Ralph G Zinner, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapyOzden Altundag, David J Stewart, Frank V Fossella, et al.Investigational New Drugs|April 24, 2013
Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumorsAung Naing, Siqing Fu, Ralph G Zinner, et al.Pageof 6